MicroRNA29 a mechanistic contributor and potential biomarker in atrial fibrillation /
MiR29 likely plays a role in atrial fibrotic remodeling and may have value as a biomarker and/or therapeutic target.
Saved in:
Main Authors: |
Dawson Kristin Wakili Reza Ördög Balázs Clauss Sebastian Chen Yu Iwasaki Yuki Voigt Niels Qi Xiao Yan Sinner Moritz F Dobrev Dobromir Kääb Stefan Nattel Stanley |
---|---|
Format: | Article |
Published: |
2013-04-09
|
Series: | Circulation
127 No. 14 |
doi: | 10.1161/CIRCULATIONAHA.112.001207 |
mtmt: | 2227302 |
Online Access: | http://publicatio.bibl.u-szeged.hu/9038 |
Similar Items
-
Formulation and characterization of cationic nanoemulsions as carriers for microRNA
by: Tucak-Smajić Amina, et al.
Published: (2022) -
MicroRNAs in inflammation and response to injuries induced by environmental pollution
by: Sonkoly Enikő, et al.
Published: (2011) -
Solid lipid nanoparticles as drug delivery systems for MicroRNA
by: Tucak Amina, et al.
Published: (2021) -
Fibroblast inward-rectifier potassium current upregulation in profibrillatory atrial remodeling
by: Qi Xiao-Yan, et al.
Published: (2015) -
Atrial fibrillation is not associated with altered left atrial microrna expression profile in ischemic end-stage human heart failure [abstract] /
by: Bálint Tímea, et al.
Published: (2022)